PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1
p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates...
Gespeichert in:
Veröffentlicht in: | Biochemical and biophysical research communications 2009-02, Vol.379 (3), p.721-725 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 725 |
---|---|
container_issue | 3 |
container_start_page | 721 |
container_title | Biochemical and biophysical research communications |
container_volume | 379 |
creator | Rankin, Sherri L. Guy, Clifford S. Mearow, Karen M. |
description | p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions. |
doi_str_mv | 10.1016/j.bbrc.2008.12.075 |
format | Article |
fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_21255879</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X08025011</els_id><sourcerecordid>20254807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi1ERbeFF-CAIiH1lnTGiZ1E4lK1pSBVC4JF4mY5k0nxajdO7Wxh356EXYkbzMVz-OYfjT8hXiNkCKgv11nTBMokQJWhzKBUz8QCoYZUIhTPxQIAdCpr_H4qzmJcAyAWun4hTrGeOsiLhVh-Xt0uk9b_7AM_7DZ25JgMpVquviT8awgco_N90uyTlimwja5_SG6WV2nj-nbuLY3uyY37xHfJ1wFfipPObiK_Or7n4tv729X1h_T-093H66v7lArMxxQt6U4ydDkQYdHZulEEVkPeNJQXdTUVWl0TKKuUolKVGnOsSyZmhDI_F28PuT6OzkRyI9MP8n3PNBqJUqmqrCfq4kANwT_uOI5m6yLxZmN79rtotK40ViX-F5QgVVH92SsPIAUfY-DODMFtbdgbBDNLMWszSzGzFIPSTFKmoTfH9F2z5fbvyNHCBLw7ADx92ZPjMF_EPXHrwnxQ692_8n8D0rabGQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20254807</pqid></control><display><type>article</type><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</creator><creatorcontrib>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</creatorcontrib><description>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2008.12.075</identifier><identifier>PMID: 19114034</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Animals ; Cell Line, Tumor ; Cell Nucleus - enzymology ; CHROMATIN ; Chromatin immunoprecipitation ; DNA ; DNA - metabolism ; Down-Regulation ; ELECTROPHORESIS ; Electrophoretic Mobility Shift Assay ; Gene Expression Regulation ; GENE REGULATION ; Laminin ; Laminin - metabolism ; Laminin - pharmacology ; MUTANTS ; Mutation ; NERVOUS SYSTEM ; Neurons - drug effects ; Neurons - enzymology ; Nuclear localization ; p75NTR ; PROMOTERS ; PTEN ; PTEN Phosphohydrolase - genetics ; PTEN Phosphohydrolase - metabolism ; Rats ; Receptor, Nerve Growth Factor - genetics ; RECEPTORS ; Sp1 ; Sp1 Transcription Factor - metabolism ; STIMULATION ; TRANSCRIPTION ; TRANSCRIPTION FACTORS ; Transcription, Genetic - drug effects</subject><ispartof>Biochemical and biophysical research communications, 2009-02, Vol.379 (3), p.721-725</ispartof><rights>2008 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</citedby><cites>FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2008.12.075$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19114034$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21255879$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Rankin, Sherri L.</creatorcontrib><creatorcontrib>Guy, Clifford S.</creatorcontrib><creatorcontrib>Mearow, Karen M.</creatorcontrib><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Animals</subject><subject>Cell Line, Tumor</subject><subject>Cell Nucleus - enzymology</subject><subject>CHROMATIN</subject><subject>Chromatin immunoprecipitation</subject><subject>DNA</subject><subject>DNA - metabolism</subject><subject>Down-Regulation</subject><subject>ELECTROPHORESIS</subject><subject>Electrophoretic Mobility Shift Assay</subject><subject>Gene Expression Regulation</subject><subject>GENE REGULATION</subject><subject>Laminin</subject><subject>Laminin - metabolism</subject><subject>Laminin - pharmacology</subject><subject>MUTANTS</subject><subject>Mutation</subject><subject>NERVOUS SYSTEM</subject><subject>Neurons - drug effects</subject><subject>Neurons - enzymology</subject><subject>Nuclear localization</subject><subject>p75NTR</subject><subject>PROMOTERS</subject><subject>PTEN</subject><subject>PTEN Phosphohydrolase - genetics</subject><subject>PTEN Phosphohydrolase - metabolism</subject><subject>Rats</subject><subject>Receptor, Nerve Growth Factor - genetics</subject><subject>RECEPTORS</subject><subject>Sp1</subject><subject>Sp1 Transcription Factor - metabolism</subject><subject>STIMULATION</subject><subject>TRANSCRIPTION</subject><subject>TRANSCRIPTION FACTORS</subject><subject>Transcription, Genetic - drug effects</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi1ERbeFF-CAIiH1lnTGiZ1E4lK1pSBVC4JF4mY5k0nxajdO7Wxh356EXYkbzMVz-OYfjT8hXiNkCKgv11nTBMokQJWhzKBUz8QCoYZUIhTPxQIAdCpr_H4qzmJcAyAWun4hTrGeOsiLhVh-Xt0uk9b_7AM_7DZ25JgMpVquviT8awgco_N90uyTlimwja5_SG6WV2nj-nbuLY3uyY37xHfJ1wFfipPObiK_Or7n4tv729X1h_T-093H66v7lArMxxQt6U4ydDkQYdHZulEEVkPeNJQXdTUVWl0TKKuUolKVGnOsSyZmhDI_F28PuT6OzkRyI9MP8n3PNBqJUqmqrCfq4kANwT_uOI5m6yLxZmN79rtotK40ViX-F5QgVVH92SsPIAUfY-DODMFtbdgbBDNLMWszSzGzFIPSTFKmoTfH9F2z5fbvyNHCBLw7ADx92ZPjMF_EPXHrwnxQ692_8n8D0rabGQ</recordid><startdate>20090213</startdate><enddate>20090213</enddate><creator>Rankin, Sherri L.</creator><creator>Guy, Clifford S.</creator><creator>Mearow, Karen M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7TM</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20090213</creationdate><title>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</title><author>Rankin, Sherri L. ; Guy, Clifford S. ; Mearow, Karen M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-1ac6f2e0f30cc14fa9b5c0a603bbc34988881a69c05a555c757613197ecee1073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Animals</topic><topic>Cell Line, Tumor</topic><topic>Cell Nucleus - enzymology</topic><topic>CHROMATIN</topic><topic>Chromatin immunoprecipitation</topic><topic>DNA</topic><topic>DNA - metabolism</topic><topic>Down-Regulation</topic><topic>ELECTROPHORESIS</topic><topic>Electrophoretic Mobility Shift Assay</topic><topic>Gene Expression Regulation</topic><topic>GENE REGULATION</topic><topic>Laminin</topic><topic>Laminin - metabolism</topic><topic>Laminin - pharmacology</topic><topic>MUTANTS</topic><topic>Mutation</topic><topic>NERVOUS SYSTEM</topic><topic>Neurons - drug effects</topic><topic>Neurons - enzymology</topic><topic>Nuclear localization</topic><topic>p75NTR</topic><topic>PROMOTERS</topic><topic>PTEN</topic><topic>PTEN Phosphohydrolase - genetics</topic><topic>PTEN Phosphohydrolase - metabolism</topic><topic>Rats</topic><topic>Receptor, Nerve Growth Factor - genetics</topic><topic>RECEPTORS</topic><topic>Sp1</topic><topic>Sp1 Transcription Factor - metabolism</topic><topic>STIMULATION</topic><topic>TRANSCRIPTION</topic><topic>TRANSCRIPTION FACTORS</topic><topic>Transcription, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rankin, Sherri L.</creatorcontrib><creatorcontrib>Guy, Clifford S.</creatorcontrib><creatorcontrib>Mearow, Karen M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rankin, Sherri L.</au><au>Guy, Clifford S.</au><au>Mearow, Karen M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2009-02-13</date><risdate>2009</risdate><volume>379</volume><issue>3</issue><spage>721</spage><epage>725</epage><pages>721-725</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>p75NTR is expressed throughout the nervous system and its dysregulation is associated with pathological conditions. We have recently demonstrated a signalling cascade initiated by laminin (LN), which upregulates PTEN and downregulates p75NTR. Here we investigate the mechanism by which PTEN modulates p75NTR. Studies using PTEN mutants show that its protein phosphatase activity directly modulates p75NTR protein expression. Nuclear relocalization of PTEN subsequent to LN stimulation suggests transcriptional control of p75NTR expression, which was confirmed following EMSA and ChIP analysis of Sp1 transcription factor binding activity. LN and PTEN independently decrease the DNA-binding ability of PTEN to the p75NTR promoter. Sp1 regulation of p75NTR occurs via dephosphorylation of Sp1, thus reducing p75NTR transcription and protein expression. This mechanism represents a novel regulatory pathway which controls the expression level of a receptor with broad implications not only for the development of the nervous system but also for progression of pathological conditions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>19114034</pmid><doi>10.1016/j.bbrc.2008.12.075</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2009-02, Vol.379 (3), p.721-725 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_osti_scitechconnect_21255879 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | 60 APPLIED LIFE SCIENCES Animals Cell Line, Tumor Cell Nucleus - enzymology CHROMATIN Chromatin immunoprecipitation DNA DNA - metabolism Down-Regulation ELECTROPHORESIS Electrophoretic Mobility Shift Assay Gene Expression Regulation GENE REGULATION Laminin Laminin - metabolism Laminin - pharmacology MUTANTS Mutation NERVOUS SYSTEM Neurons - drug effects Neurons - enzymology Nuclear localization p75NTR PROMOTERS PTEN PTEN Phosphohydrolase - genetics PTEN Phosphohydrolase - metabolism Rats Receptor, Nerve Growth Factor - genetics RECEPTORS Sp1 Sp1 Transcription Factor - metabolism STIMULATION TRANSCRIPTION TRANSCRIPTION FACTORS Transcription, Genetic - drug effects |
title | PTEN downregulates p75NTR expression by decreasing DNA-binding activity of Sp1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T03%3A49%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PTEN%20downregulates%20p75NTR%20expression%20by%20decreasing%20DNA-binding%20activity%20of%20Sp1&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Rankin,%20Sherri%20L.&rft.date=2009-02-13&rft.volume=379&rft.issue=3&rft.spage=721&rft.epage=725&rft.pages=721-725&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2008.12.075&rft_dat=%3Cproquest_osti_%3E20254807%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20254807&rft_id=info:pmid/19114034&rft_els_id=S0006291X08025011&rfr_iscdi=true |